On September 9, 2022 Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, reported that members of the senior management team will participate and present at the following industry conferences in the U.S. in September (Press release, Antengene, SEP 9, 2022, View Source [SID1234619341]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: Baird’s 2022 Global Healthcare Conference (in-person)
Date: September 13-14, 2022
Location: New York
Format: Company Presentation (September 14 at 2:35 p.m. ET) and 1×1 Meetings
Participation: In-person

Event: Macquarie’s "Looking into a Post-COVID World" Pan Asia Conference (in-person)
Date: September 28-29, 2022
Format: 1x1s and Group Meetings
Participation: In-person